Yajie F. Lu

No. 15 Changle West Road
Xi'an, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 39 publications

SPP1-positive macrophages drive trastuzumab resistance in HER2-positive breast cancer.

SPP1-positive macrophages drive trastuzumab resistance in HER2-positive breast cancer.

Journal: Cell communication and signaling : CCS

Published: February 09, 2026

Charge-Reversal Near-Infrared II Polymeric Amphiphiles Enable Efficient Combinatorial Gene and Mild Photothermal Therapy for Osteosarcoma.

Charge-Reversal Near-Infrared II Polymeric Amphiphiles Enable Efficient Combinatorial Gene and Mild Photothermal Therapy for Osteosarcoma.

Journal: ACS nano

Published: February 04, 2026

Comparison of clinical features and disease-related factors in vitiligo patients between 2001-2011 and 2022-2024

Comparison of clinical features and disease-related factors in vitiligo patients between 2001-2011 and 2022-2024

Journal: Zhonghua yi xue za zhi

Published: December 16, 2025

Effect of extramedullary fixation under different biomechanical modes on osseointegration of short-stem intramedullary implants: an experimental study.

Effect of extramedullary fixation under different biomechanical modes on osseointegration of short-stem intramedullary implants: an experimental study.

Journal: Medical engineering & physics

Published: October 05, 2025

Evaluating the clinical potential of bioceramic-rods for revascularization in osteonecrosis of the femoral head: a systematic review.

Evaluating the clinical potential of bioceramic-rods for revascularization in osteonecrosis of the femoral head: a systematic review.

Journal: International orthopaedics

Published: October 01, 2024

The Potential Therapeutic Targets of Anlotinib in Osteosarcoma: Characterization Based on Patient-Derived Xenografts and Next-Generation Sequencing.

The Potential Therapeutic Targets of Anlotinib in Osteosarcoma: Characterization Based on Patient-Derived Xenografts and Next-Generation Sequencing.

Journal: Cancer medicine

Published: May 21, 2024

CXCL12+ tumor-associated endothelial cells promote immune resistance in hepatocellular carcinoma.

CXCL12+ tumor-associated endothelial cells promote immune resistance in hepatocellular carcinoma.

Journal: Journal of hepatology

Published: March 25, 2024

Identifying specific TLS-associated genes as potential biomarkers for predicting prognosis and evaluating the efficacy of immunotherapy in soft tissue sarcoma.

Identifying specific TLS-associated genes as potential biomarkers for predicting prognosis and evaluating the efficacy of immunotherapy in soft tissue sarcoma.

Journal: Frontiers in immunology

Published: January 18, 2024

Predicting chemosensitivity based on mini patient-derived xenografts in osteosarcoma patients: A retrospective study.

Predicting chemosensitivity based on mini patient-derived xenografts in osteosarcoma patients: A retrospective study.

Journal: Journal of cancer research and therapeutics

Published: April 03, 2023

Reconstructing avascular necrotic femoral head through a bioactive β-TCP system: From design to application.

Reconstructing avascular necrotic femoral head through a bioactive β-TCP system: From design to application.

Journal: Bioactive materials

Published: March 09, 2023

Redefining the Incidence and Profile of Fluoropyrimidine-Associated Cardiotoxicity in Cancer Patients: A Systematic Review and Meta-Analysis.

Redefining the Incidence and Profile of Fluoropyrimidine-Associated Cardiotoxicity in Cancer Patients: A Systematic Review and Meta-Analysis.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: February 10, 2023

Evaluation of Anlotinib Combined with Adriamycin and Ifosfamide as Conversion Therapy for Unresectable Soft Tissue Sarcomas.

Evaluation of Anlotinib Combined with Adriamycin and Ifosfamide as Conversion Therapy for Unresectable Soft Tissue Sarcomas.

Journal: Cancers

Published: December 11, 2022

Showing 1-12 of 39

Last Updated: 09/26/2026